HawkInsight

  • Contact Us
  • App
  • English

Oncolytics Biotech receives Nasdaq non-compliance notice

Oncolytics Biotech (NASDAQ:ONCY) received a delinquency notification letter from Nasdaq indicating that the company is not currently in compliance with the minimum bid price requirement. ONCY has a period of 180 calendar days from the date of the notice, or until August 12, 2025, to regain compliance with the minimum bid price requirement. Source: Press release

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More